ACh | Acetylcholine |
AChE | Acetylcholinesterase |
BChE | Butyrylcholinesterase |
CCEP | Comprehensive Clinical Evaluation Program |
CNS | Central nervous system |
COPD | Chronic obstruction pulmonary disease |
CW | Chemical warfare |
DFP | Diisopropyl fluorophosphate |
DoD | Department of Defense |
EEG | Electroencephalogram, a measure of brain activity |
EMG | Electromyography |
FDA | Food and Drug Administration |
GABA | Gamma amino butyric acid |
GI | Gastrointestinal |
IND | Investigational new drug |
IOM | Institute of Medicine |
LD50 | Lethal dose for 50 percent of subjects |
MCS | Multiple chemical sensitivity |
NAPP | Nerve Agent Pretreatment Pack |
NAPS | Nerve Agent Pretreatment System |
NMJ | Neuromuscular junction |
NTE | Neurotoxic esterase |
OP | Organophosphate |
OPIDN | Organophosphate induced delayed neurotoxicity |
PAC | Presidential Advisory Commission |
2PAM | Pralidoxime, a postexposure treatment for nerve agent protection |
PB | Pyridostigmine bromide |
PGW | Persian Gulf War |
PNS | Peripheral nervous system |
PON | Paraoxonase |
PR | Protective ratio; LD50 with treatment divided by LD50 without treatment |
PTSD | Posttraumatic stress disorder |
RBC | Red blood cell |
REM | Rapid eye movement |
SPECT imaging | Single Photon Emission Computer Tomography, a method of evaluating regional (brain) blood flow at a cross section in time |
SVN | Sindbis virus strain |